Prenetics Global Limited announced an executive leadership change to ensure the company realizes the full potential of its broad genetics and digital testing platform and as a commitment to the EMEA market. To be effective immediately, Dr. Bayju Thakar is appointed as CEO and shall join the board of directors for Prenetics EMEA Limited (“Prenetics EMEA”), a wholly owned subsidiary of Prenetics Global Limited. Dr. Thakar has more than 20 years of healthcare and digital health, M&A, strategic partnerships and board experience.

Most recently, Dr. Thakar served as Co-Founder and former CEO of Doctor Care Anywhere Group PLC. Dr. Thakar trained as a medical doctor at King's College, London, and then practised in both General and Emergency medicine before a move to consulting at McKinsey & Company.